Endothelial nitric oxide synthase: the Cinderella of inflammation?
- PMID: 12559774
- DOI: 10.1016/S0165-6147(02)00049-4
Endothelial nitric oxide synthase: the Cinderella of inflammation?
Abstract
A hallmark of inflammation is increased vascular permeability. Increases in vascular permeability and the migration of inflammatory cells are linked to complex interactions of inflammatory mediators with the vascular endothelium. Normally, endothelial nitric oxide synthase (eNOS) produces a tonic amount of nitric oxide (NO), which is responsible for the homeostasis between the endothelium and surrounding tissues. However, most agonists that act on endothelial cells cause a series of post-translational modifications that influence eNOS activity. Furthermore, stimulation by shear stress, autacoids or growth factors either induces eNOS or shifts it to a more active state, which produces a burst of NO. Here, we highlight recent findings about eNOS and propose how new pharmacological tools can be used to dissect the involvement and contribution of eNOS to inflammatory responses.
Similar articles
-
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo.Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):904-8. doi: 10.1073/pnas.0408906102. Epub 2005 Jan 7. Proc Natl Acad Sci U S A. 2005. PMID: 15640348 Free PMC article.
-
A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.J Mol Cell Cardiol. 2005 Oct;39(4):595-603. doi: 10.1016/j.yjmcc.2005.06.012. J Mol Cell Cardiol. 2005. PMID: 16099468
-
Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel.Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):405-12. doi: 10.1161/01.ATV.0000109171.50229.33. Epub 2003 Dec 1. Arterioscler Thromb Vasc Biol. 2004. PMID: 14656742 Review.
-
Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells.Biol Reprod. 2003 Sep;69(3):1053-9. doi: 10.1095/biolreprod.102.013474. Epub 2003 May 28. Biol Reprod. 2003. PMID: 12773424
-
Dysfunction of endothelial nitric oxide synthase and atherosclerosis.Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):998-1005. doi: 10.1161/01.ATV.0000125114.88079.96. Epub 2004 Mar 4. Arterioscler Thromb Vasc Biol. 2004. PMID: 15001455 Review.
Cited by
-
Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity.Immun Ageing. 2012 Nov 15;9(1):26. doi: 10.1186/1742-4933-9-26. Immun Ageing. 2012. PMID: 23153280 Free PMC article.
-
Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study.J Am Heart Assoc. 2025 Jun 3;14(11):e040214. doi: 10.1161/JAHA.124.040214. Epub 2025 May 26. J Am Heart Assoc. 2025. PMID: 40417813 Free PMC article.
-
Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation.Br J Pharmacol. 2009 Jul;157(6):1014-23. doi: 10.1111/j.1476-5381.2009.00292.x. Epub 2009 Jun 5. Br J Pharmacol. 2009. PMID: 19508391 Free PMC article.
-
Requirement of phosphorylatable endothelial nitric oxide synthase at Ser-1177 for vasoinhibin-mediated inhibition of endothelial cell migration and proliferation in vitro.Endocrine. 2014 Mar;45(2):263-70. doi: 10.1007/s12020-013-9964-4. Epub 2013 May 3. Endocrine. 2014. PMID: 23640371
-
KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.J Exp Med. 2004 May 17;199(10):1305-15. doi: 10.1084/jem.20031132. Epub 2004 May 10. J Exp Med. 2004. PMID: 15136591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources